Vildagliptin, with or without metformin, for fatty liver and diabetes
Treatments studied
Part of Hormones & metabolism clinical trials.
This trial studies how vildagliptin compares to vildagliptin plus metformin in people who have fatty liver disease along with type 2 diabetes. It may help find the safest and most effective way to improve liver health and diabetes control.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have fatty liver disease (NAFLD) and type 2 diabetes
- You do not have viral hepatitis (for example, hepatitis B or C)
- Your Child-Pugh score is 6 or less (a measure of liver function severity)
- You do not have kidney problems (renal impairment)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether adding empagliflozin (a diabetes pill) to your current medicines (alogliptin and metformin) helps manage blood sugar better. It may be an option if your blood sugar is not well controlled with your current treatment.
This trial compares two medicines, vildagliptin and metformin, to see which works better for women with Polycystic Ovary Syndrome (PCOS). The goal is to find a safe and effective treatment that may help manage PCOS symptoms.
This trial tests whether combining alogliptin with Actoplus Met (a type 2 diabetes medicine) can improve blood sugar, cholesterol, and pancreas health in people who have both type 2 diabetes and fatty liver disease (MAFLD). If you have not taken any diabetes medication or insulin in the past six months, this study might be a good fit for you.
This study tests whether a medicine called henagliflozin can help reduce fat in the liver for people with type 2 diabetes and non-alcoholic fatty liver disease. It may help improve liver health and blood sugar control at the same time.
This trial is testing if adding a combination of SGLT-2 inhibitor and GLP-1 receptor agonist to metformin can improve blood sugar control in people with type 2 diabetes who are not meeting their goals on metformin alone or with one other pill.
This trial tests two diabetes pills (pioglitazone and empagliflozin) to see if they can reduce liver fat in people with type 2 diabetes and fatty liver disease. It may help if your diabetes is not well controlled and you have a fatty liver confirmed by a special ultrasound scan.
Hear when a new DM trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.